Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ARID2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ARID2 mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARID2 mRNA | decreases expression | 19150397
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of ARID2 mRNA | increases expression | 18042831
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of ARID2 mRNA | decreases expression | 18927307
|
C041786 |
palm oil |
palm oil results in increased expression of ARID2 mRNA | increases expression | 18042831
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARID2 mRNA | affects binding|increases activity|increases expression | 19710929
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in increased expression of ARID2 mRNA | affects cotreatment|increases expression | 19465110
|
C025643 |
vinclozolin |
vinclozolin affects the expression of ARID2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 14514962 15322242 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.87 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.80 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.15 | 15238619 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.97 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.04 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.04 | 16705839 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.10 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.10 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 15340226 8697196 15668235 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.62 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 16303861 18259882 17454858 17159606 18509181 16391804 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.58 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.77 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.77 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.47 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.47 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.47 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.60 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.23 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.23 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
8.39 | 18296743 19551842 17967931 19004024 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.39 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.50 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.50 | 20067830 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.22 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.62 | 16417039 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.14 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.14 | 12621046 15340226 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 8697196 16959395 16354765 18606429 15340226 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.80 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.83 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.17 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.24 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.24 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.67 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.67 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.94 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.94 | 16705839 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.02 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.98 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.72 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.72 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.14 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.14 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.29 | 17159606 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.32 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.32 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.24 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.03 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.57 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.01 | 8761367 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.58 | 18674790 21332399 19632207 11836018 18457598 20518802 16723640 17217161 20132043 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.58 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.54 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.54 | 16049721 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.46 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
10.46 | 19015723 18220299 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.22 | 18220299 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.22 | 18629315 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.32 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.32 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.36 | 15723263 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.24 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.24 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.96 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.96 | 10091137 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.92 | 16723640 |